Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation - A veterans affairs cooperative studies program substudy

被引:179
作者
Singh, Steven N.
Tang, X. Charlene
Singh, Bramah N.
Dorian, Paul
Reda, Domenic J.
Harris, Crystal L.
Fletcher, Ross D.
Sharma, Satish C.
Atwood, J. Edwin
Jacobson, Alan K.
Lewis, Daniel, Jr.
Lopez, Becky
Raisch, Dennis W.
Ezekowitz, Michael D.
机构
[1] Vet Affairs Med Ctr, Washington, DC 20422 USA
[2] Vet Affairs Med Ctr, Hines, IL USA
[3] Vet Affairs Med Ctr, Los Angeles, CA USA
[4] Vet Affairs Med Ctr, Albuquerque, NM USA
[5] Vet Affairs Med Ctr, Providence, RI USA
[6] Vet Affairs Med Ctr, Loma Linda, CA USA
[7] Vet Affairs Med Ctr, Kansas City, MO USA
[8] Univ Toronto, Toronto, ON, Canada
[9] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[10] Lankenau Inst Med Res, Philadelphia, PA USA
关键词
D O I
10.1016/j.jacc.2006.03.051
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVES The purpose of this study was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent atrial fibrillation (AF) converted to sinus rhythm (SR) compared with those remaining in or reverting to AF. BACKGROUND Restoration of SR in patients with AF improving QOL and EP remains controversial. METHODS Patients with persistent AF were randomized double-blind to amiodarone, sotalol, or placebo. Those not achieving SR at day 28 were cardioverted and classified into SR or AF groups at 8 weeks (n = 624) and 1 year (n = 556). The QOL (SF-36), symptom checklist (SCL), specific activity scale (SAS), AF severity scale (AFSS), and EP were assessed. RESULTS Favorable changes were seen in SR patients at 8 weeks in physical functioning (p < 0.001), physical role limitations (p = 0.03), general health (p = 0.002), and vitality (p < 0.001), and at 1 year in general health (p = 0.007) and social functioning (p = 0.02). Changes in the scores for SCL severity (p = 0.01), functional capacity (p = 0.003), and AFSS symptom burden (p < 0.001) at 8 weeks and in SCL severity (p < 0.01) and AF symptom burden (p < 0.001) at 1 year showed significant improvements in SR versus AF. Symptomatic patients were more likely to have improvement. The EP in SR versus AF was greater from baseline to 8 weeks (p = 0.01) and to 1 year (p = 0.02). The EP correlated with physical functioning and functional capacity except in the AF group at 1 year. CONCLUSIONS In patients with persistent AF, restoration and maintenance of SR was associated with improvements in QOL measures and EP. There was a strong correlation between QOL measures and EP.
引用
收藏
页码:721 / 730
页数:10
相关论文
共 30 条
[1]
BIALY D, 1992, J AM COLL CARDIOL, V19, P41
[2]
Effect of radiofrequency catheter ablation an health-related quality of life and activities of daily living in patients with recurrent arrhythmias [J].
Bubien, RS ;
KnottsDolson, SM ;
Plumb, VJ ;
Kay, GN .
CIRCULATION, 1996, 94 (07) :1585-1591
[3]
Cohen J, 1998, STAT POWER ANAL BEHA, P567
[4]
Cooper, 1994, HDB RES SYNTHESIS, P231, DOI DOI 10.7758/9781610441377.20
[5]
Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study [J].
Corley, SD ;
Epstein, AE ;
DiMarco, JP ;
Domanski, MJ ;
Geller, N ;
Greene, HL ;
Josephson, RA ;
Kellen, JC ;
Klein, RC ;
Krahn, AD ;
Mickel, M ;
Mitchell, LB ;
Nelson, JD ;
Rosenberg, Y ;
Schron, E ;
Shemanski, L ;
Waldo, AL ;
Wyse, DG .
CIRCULATION, 2004, 109 (12) :1509-1513
[6]
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy [J].
Dorian, P ;
Jung, W ;
Newman, D ;
Paquette, M ;
Wood, K ;
Ayers, GM ;
Camm, J ;
Akhtar, M ;
Luderitz, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) :1303-1309
[7]
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation [J].
Dorian, P ;
Paquette, M ;
Newman, D ;
Green, M ;
Connolly, SJ ;
Talajic, M ;
Roy, D .
AMERICAN HEART JOURNAL, 2002, 143 (06) :984-990
[8]
WARFARIN IN THE PREVENTION OF STROKE ASSOCIATED WITH NONRHEUMATIC ATRIAL-FIBRILLATION [J].
EZEKOWITZ, MD ;
BRIDGERS, SL ;
JAMES, KE ;
CARLINER, NH ;
COLLING, CL ;
GORNICK, CC ;
KRAUSESTEINRAUF, H ;
KURTZKE, JF ;
NAZARIAN, SM ;
RADFORD, MJ ;
RICKLES, FR ;
SHABETAI, R ;
DEYKIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) :1406-1412
[9]
Frost MH, 2002, MAYO CLIN PROC, V77, P488
[10]
COMPARATIVE REPRODUCIBILITY AND VALIDITY OF SYSTEMS FOR ASSESSING CARDIOVASCULAR FUNCTIONAL CLASS - ADVANTAGES OF A NEW SPECIFIC ACTIVITY SCALE [J].
GOLDMAN, L ;
HASHIMOTO, B ;
COOK, EF ;
LOSCALZO, A .
CIRCULATION, 1981, 64 (06) :1227-1234